Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial

NCT07576452 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT07576452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07576452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
December 1, 2030
Enrollment
240 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)